Astrana Health, Inc. (ASTH)
USD 30.18
(2.1%)
USD 30.18
(2.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 123.68 Million USD | -3.81% |
| 2022 | 112.07 Million USD | 22.1% |
| 2021 | 100.65 Million USD | 171.2% |
| 2020 | 206.27 Million USD | -23.58% |
| 2019 | 48.85 Million USD | -52.76% |
| 2018 | 102.49 Million USD | 96.87% |
| 2017 | 68.86 Million USD | 0.0% |
| 2015 | -7.35 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 35.23 Million USD | 226.15% |
| 2024 Q2 | 37.5 Million USD | 30.64% |
| 2023 Q1 | 33.36 Million USD | 100.46% |
| 2023 Q4 | 9.95 Million USD | -78.57% |
| 2023 Q2 | 38.51 Million USD | 15.44% |
| 2023 Q3 | 46.44 Million USD | 20.59% |
| 2023 FY | - USD | -3.81% |
| 2022 Q2 | 19.73 Million USD | -35.48% |
| 2022 FY | - USD | 22.1% |
| 2022 Q4 | 16.64 Million USD | -69.65% |
| 2022 Q3 | 54.84 Million USD | 177.94% |
| 2022 Q1 | 30.58 Million USD | 359.23% |
| 2021 Q4 | 6.66 Million USD | -88.48% |
| 2021 Q2 | 25.22 Million USD | 0.0% |
| 2021 Q3 | 57.83 Million USD | 129.26% |
| 2021 FY | - USD | 171.2% |
| 2020 FY | - USD | -23.58% |
| 2019 FY | - USD | -52.76% |
| 2018 FY | - USD | 96.87% |
| 2017 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 34.596% |
| Addus HomeCare Corporation | 106.55 Million USD | -16.076% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -336.875% |
| Amedisys, Inc. | 216.91 Million USD | 42.978% |
| American Oncology Network, Inc. | -39.35 Million USD | 414.32% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -178.903% |
| IMAC Holdings, Inc. | -5.94 Million USD | 2179.91% |
| biote Corp. | 9.23 Million USD | -1239.485% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 1287.334% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 4.366% |
| COMPASS Pathways plc | -123.8 Million USD | 199.908% |
| DocGo Inc. | 32.72 Million USD | -277.96% |
| The Ensign Group, Inc. | 353.23 Million USD | 64.984% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -64.452% |
| InnovAge Holding Corp. | 1.15 Million USD | -10618.198% |
| Assure Holdings Corp. | -19.82 Million USD | 723.931% |
| The Joint Corp. | 9.14 Million USD | -1253.006% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 217.881% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 895.183% |
| ModivCare Inc. | -26.75 Million USD | 562.385% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -32084.853% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 2214.686% |
| Option Care Health, Inc. | 376.79 Million USD | 67.174% |
| P3 Health Partners Inc. | -81.07 Million USD | 252.568% |
| P3 Health Partners Inc. | -81.07 Million USD | 252.568% |
| The Pennant Group, Inc. | 30.36 Million USD | -307.284% |
| Surgery Partners, Inc. | 446.1 Million USD | 72.273% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 4461.529% |
| Talkspace, Inc. | -22.01 Million USD | 661.886% |
| Talkspace, Inc. | -22.01 Million USD | 661.886% |
| The Oncology Institute, Inc. | -70.45 Million USD | 275.559% |
| The Oncology Institute, Inc. | -70.45 Million USD | 275.559% |